The impact of admission blood glucose level on patients with community-acquired pneumonia
| Autor: | Tamer M. Ali, Dina Ruby Sultan, Hala M. Salem |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
community-acquired pneumonia medicine.drug_class medicine.medical_treatment Antibiotics antibiotics 03 medical and health sciences 0302 clinical medicine Community-acquired pneumonia Internal medicine Diabetes mellitus medicine blood glucose lcsh:RC705-779 Mechanical ventilation business.industry Mortality rate lcsh:Medical emergencies. Critical care. Intensive care. First aid 030208 emergency & critical care medicine lcsh:Diseases of the respiratory system lcsh:RC86-88.9 medicine.disease Antibiotic coverage hospital stay Pneumonia 030228 respiratory system Population study hyperglycemia business |
| Zdroj: | The Egyptian Journal of Bronchology, Vol 13, Iss 4, Pp 551-555 (2019) |
| ISSN: | 2314-8551 1687-8426 |
| Popis: | Background Pneumonia is one of the most common diseases with a high hospitalization rate. Many studies have suggested that there is a correlation between pre-existing diabetes and the alterations in serum glucose levels in patients with community-acquired pneumonia (CAP) and high death rate. Aim To study the impact of admission blood glucose level on patients’ outcomes with CAP. Patients and methods Sixty (30 nondiabetic and 30 diabetic patients) consecutive hospitalized adult patients with CAP were recruited over a 1-year period. Data on patients’ outcomes including duration of hospital stay, duration of antibiotic treatment, increase in oxygen requirements, increase in antibiotics coverage, ICU admission, mechanical ventilation, and in-hospital mortality were collected. Results Admission blood glucose level was elevated in diabetic patients (the mean plasma glucose level was 258.86 ±116.15 mg/dl in diabetics and 151.13±51.23 mg/dl in nondiabetics). There were statistically significant increases in the duration of hospital stay (7.633±3.567 nondiabetic vs. 11.267±4.291 diabetic patients in days), duration of antibiotic treatment (7.633±3.567 nondiabetic vs. 11.267±4.291 diabetic patients in days), increase in O2 requirements (33.33 vs.70%), increase in antibiotics coverage (16.67 vs. 63.33%), and ICU admission (30 vs. 63.33%) in the diabetic group on comparing nondiabetic versus diabetic patients with CAP. Also, the previously mentioned outcomes increased significantly with increasing blood glucose levels among the entire study population. Conclusion On admission, CAP patients with increased blood glucose level, either diabetic or nondiabetic, are expected to have poor outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink